# Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

> **NCT00005022** · PHASE1 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 64 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** etoposide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00005022
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-02
- **Primary completion:** 2002-10
- **Final completion:** 2010-06
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2013-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005022, "Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*